ArticleOncotarget2018

Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium.

Giovanni Schinzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.